
Home » Prescription Drugs 2 » Apo Ipravent Nasal Spray Atrovent
APO-IPRAVENT NASAL SPRAY 0.03% is a clear colourless solution and contain 300mcg/mL or ipratropium bromide. The solution is filled into a white opaque plastic bottle closed with a white plastic pump and activator.IndicationsAPO-IPRAVENT NASAL SPRAY is indicated for the treatment and management of perennial rhinitis allergic rhinitis and vasomotor rhinitis when characterised by watery rhinorrhoea.APO-IPRAVENT NASAL SPRAY is also indicated for the symptomatic relief of rhinorrhoea associated with the common cold.Dosage and AdministrationPriming of pump is required before first use.For the treatment and management of perennial rhinitis allergic rhinitis and vasomotor rhinitis when characterised by watery rhinorrhoea:Regular TherapyAdults: Two sprays up each nostril 2 - 3 times a day. Some patients may need 3 - 4 sprays up each nostril during early therapy to obtain maximum benefit during early treatment. Children: 2 sprays up each nostril 2 times a day. Optimal dosage varies with the response of the individual patient.Intermittent TherapyPatients with occasional episodes of watery rhinorrhoea triggered by provocating factors e.g. temperature changes food and exercise should administer 2 - 4 sprays up each nostril prior to exposure.For the symptomatic relief of rhinorrhoea associated with the common coldAdults 0.03% strength: Initial dose: Two sprays into each nostril followed by two further sprays five minutes after the first spray. Subsequent doses (2-3 times per day) two sprays into each nostril. 0.06% strength Two sprays per nostril 3 or 4 times a day Treatment in the common cold has only been studied up to four days. Efficacy and safety of treatment beyond four days have not been established although there has been no evidence of adverse safety effects with longer treatment in perennial rhinitis patients.
Buy Apo Ipravent Nasal Spray Atrovent and other Prescription Drugs 2 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Apo Ipravent Nasal Spray Atrovent:
Product Type: Prescription Drugs 2
Apo-Ipravent Nasal Spray ( Atrovent Generic Ipratropium )
Apo-Ipravent Nasal Spray (Atrovent Generic Ipratropium)
Atrovent Generic Ipratropium
21mcg 30mL(345 MD) 3 x 345MD(30mL)
Atrovent Generic Ipratropium Apo-Ipravent Nasal Spray

View more
Prescription Drugs 2
Previous Product Next Product
Pharmacy:
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.


|